Detection of miRNAs among allo-HSCT patients 1-year posttransplant. The figure demonstrates the detection of miRNAs in serum among allo-HSCT recipients. (A) The panel shows the presence of different miRNAs and their expression. Red color indicates detectable levels in serum, whereas black color indicates levels below the detection limit. Patients are distributed in the vertical columns and miRNAs in the horizontal columns. (B) The pie chart illustrates the distribution of detectable levels among the 1380 miRNAs that were detected in our study. Of the miRNAs 16.9% were detected in 70 to 79 of the patients, 3.5% among 60 to 69 patients, 3.0% among 50 to 59 patients, 3.3% among 40 to 49 patients, 4.2% among 30 to 39 patients, 6.1% among 20 to 29 patients, 11.2% among 10 to 19 patients, 13.6% among 5 to 9 patients, and 38.3% among 1 to 4 patients. Some miRNAs were detected among >70 of the 79 patients in the study, whereas for other miRNAs, only a few patients demonstrated detectable levels in serum. (C) The bar graph indicates the total number of detectable miRNAs among each of the individual patient samples. The number of detectable miRNAs ranged from 243 to 636 miRNAs (median 427 detectable miRNAs).